| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.672 | 0.002 | 0.672 | 5 Hydroxytryptamine 1E antagonist | 0.388 0.005 DBMET01581 0.617 0.003 DBMET00347 | ||
| 0.658 | 0.001 | 0.658 | 5 Hydroxytryptamine 1D agonist | 0.454 0.001 DBMET01581 0.568 0.001 DBMET00347 | ||
| 0.556 | 0.004 | 0.556 | 5 Hydroxytryptamine 1 agonist | 0.361 0.005 DBMET01581 0.464 0.004 DBMET00347 | ||
| 0.513 | 0.003 | 0.514 | 5 Hydroxytryptamine 1B agonist | 0.494 0.003 DBMET01581 0.514 0.003 DBMET00347 | DBMET00347 | |
| 0.473 | 0.001 | 0.473 | 5 Hydroxytryptamine 3E antagonist | 0.331 0.004 DBMET01581 0.434 0.002 DBMET00347 | ||
| 0.468 | 0.005 | 0.468 | 5 Hydroxytryptamine agonist | 0.225 0.012 DBMET01581 0.377 0.005 DBMET00347 | ||
| 0.409 | 0.005 | 0.409 | Neurotrophic factor | 0.29 0.008 DBMET01581 0.381 0.005 DBMET00347 | ||
| 0.426 | 0.041 | 0.538 | 5 Hydroxytryptamine release stimulant | 0.171 0.152 DBMET01581 0.538 0.022 DBMET00347 | DBMET00347 | |
| 0.346 | 0.004 | 0.346 | Vasopressin 1 antagonist | 0.098 0.009 DBMET01581 0.307 0.004 DBMET00347 | ||
| 0.335 | 0.005 | 0.335 | 5 Hydroxytryptamine 1F antagonist | 0.139 0.018 DBMET01581 0.182 0.012 DBMET00347 | ||
| 0.325 | 0.004 | 0.325 | 5 Hydroxytryptamine 1B antagonist | 0.061 0.05 DBMET01581 0.24 0.006 DBMET00347 | ||
| 0.316 | 0.003 | 0.316 | Vasopressin 1B antagonist | 0.095 0.004 DBMET01581 0.307 0.003 DBMET00347 | ||
| 0.307 | 0.004 | 0.307 | 5 Hydroxytryptamine 1D antagonist | 0.069 0.039 DBMET01581 0.192 0.007 DBMET00347 | ||
| 0.302 | 0.003 | 0.302 | Oxytocin antagonist | 0.171 0.005 DBMET01581 0.291 0.003 DBMET00347 | ||
| 0.335 | 0.04 | 0.34 | Insulysin inhibitor | 0.252 0.095 DBMET01581 0.34 0.038 DBMET00347 | DBMET00347 | |
| 0.281 | 0.004 | 0.281 | Vasopressin 1A antagonist | 0.082 0.007 DBMET01581 0.244 0.004 DBMET00347 | ||
| 0.275 | 0.004 | 0.275 | Antidiuretic hormone antagonist | 0.118 0.01 DBMET01581 0.25 0.005 DBMET00347 | ||
| 0.241 | 0.005 | 0.241 | Prolactin inhibitor | 0.165 0.017 DBMET01581 0.15 0.022 DBMET00347 | ||
| 0.238 | 0.004 | 0.238 | 5 Hydroxytryptamine 5A antagonist | 0.068 0.033 DBMET01581 0.192 0.005 DBMET00347 | ||
| 0.22 | 0.004 | 0.22 | Histamine N-methyltransferase inhibitor | 0.154 0.013 DBMET01581 0.142 0.017 DBMET00347 | ||
| 0.211 | 0.005 | 0.211 | 5 Hydroxytryptamine 5 antagonist | 0.057 0.042 DBMET01581 0.178 0.005 DBMET00347 | ||
| 0.215 | 0.031 | 0.215 | 5 Hydroxytryptamine antagonist | 0.147 0.051 DBMET00347 | ||
| 0.195 | 0.014 | 0.195 | Alpha 2a adrenoreceptor antagonist | 0.166 0.019 DBMET00347 | ||
| 0.18 | 0.021 | 0.18 | Alpha 2 adrenoreceptor antagonist | 0.142 0.029 DBMET00347 | ||
| 0.164 | 0.005 | 0.164 | 5 Hydroxytryptamine 6 antagonist | 0.05 0.049 DBMET01581 0.126 0.009 DBMET00347 | ||
| 0.16 | 0.004 | 0.16 | Vasopressin 2 antagonist | 0.108 0.005 DBMET01581 0.147 0.004 DBMET00347 | ||
| 0.281 | 0.13 | 0.281 | Antiobesity | 0.25 0.156 DBMET00347 | ||
| 0.156 | 0.017 | 0.181 | Metalloproteinase-2 inhibitor | 0.181 0.012 DBMET00347 | DBMET00347 | |
| 0.176 | 0.04 | 0.176 | CF transmembrane conductance regulator agonist | 0.156 0.067 DBMET00347 | ||
| 0.32 | 0.187 | 0.366 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.366 0.133 DBMET00347 | DBMET00347 | |
| 0.292 | 0.164 | 0.512 | Calcium channel L-type activator | 0.231 0.228 DBMET01581 0.512 0.023 DBMET00347 | DBMET00347 | |
| 0.175 | 0.055 | 0.175 | Acetylcholine M1 receptor antagonist | 0.142 0.082 DBMET00347 | ||
| 0.122 | 0.004 | 0.122 | Aggrecanase 1 inhibitor | 0.05 0.014 DBMET01581 0.116 0.004 DBMET00347 | ||
| 0.118 | 0.002 | 0.118 | 5 Hydroxytryptamine 6 agonist | 0.042 0.006 DBMET01581 0.045 0.005 DBMET00347 | ||
| 0.134 | 0.02 | 0.174 | Metalloproteinase-9 inhibitor | 0.174 0.011 DBMET00347 | DBMET00347 | |
| 0.131 | 0.032 | 0.131 | 5 Hydroxytryptamine 2C antagonist | 0.098 0.047 DBMET00347 | ||
| 0.118 | 0.02 | 0.158 | Matrix metalloproteinase inhibitor | 0.158 0.013 DBMET00347 | DBMET00347 | |
| 0.142 | 0.044 | 0.142 | 5 Hydroxytryptamine 2B antagonist | 0.094 0.09 DBMET01581 | ||
| 0.128 | 0.032 | 0.128 | Protein kinase C delta inhibitor | 0.105 0.048 DBMET01581 0.126 0.033 DBMET00347 | ||
| 0.108 | 0.02 | 0.136 | Neutrophil collagenase inhibitor | 0.136 0.014 DBMET00347 | DBMET00347 | |
| 0.113 | 0.027 | 0.113 | Somatostatin 1 agonist | 0.094 0.038 DBMET01581 0.102 0.032 DBMET00347 | ||
| 0.095 | 0.011 | 0.095 | Neurokinin 2 antagonist | 0.038 0.033 DBMET01581 0.061 0.019 DBMET00347 | ||
| 0.177 | 0.098 | 0.177 | Interleukin antagonist | 0.144 0.122 DBMET00347 | ||
| 0.103 | 0.025 | 0.151 | 5 Hydroxytryptamine uptake inhibitor | 0.151 0.016 DBMET00347 | DBMET00347 | |
| 0.09 | 0.014 | 0.09 | Glycine transporter inhibitor | 0.063 0.023 DBMET00347 | ||
| 0.089 | 0.017 | 0.144 | Matrix metalloproteinase (membrane-type) inhibitor | 0.144 0.009 DBMET00347 | DBMET00347 | |
| 0.071 | 0.005 | 0.08 | GHS receptor antagonist | 0.034 0.018 DBMET01581 0.08 0.005 DBMET00347 | DBMET00347 | |
| 0.157 | 0.095 | 0.157 | Lipocortins synthesis antagonist | 0.139 0.123 DBMET01581 0.147 0.109 DBMET00347 | ||
| 0.08 | 0.018 | 0.081 | Factor Xa inhibitor | 0.046 0.032 DBMET01581 0.081 0.018 DBMET00347 | DBMET00347 | |
| 0.09 | 0.03 | 0.09 | CXC chemokine receptor antagonist | 0.08 0.037 DBMET00347 | ||
| 0.073 | 0.013 | 0.073 | Growth hormone secretagogue receptor agonist | 0.062 0.015 DBMET00347 | ||
| 0.077 | 0.018 | 0.077 | Calcium channel P-type blocker | |||
| 0.092 | 0.033 | 0.092 | CC chemokine 5 receptor agonist | 0.081 0.06 DBMET00347 | ||
| 0.146 | 0.09 | 0.155 | Growth hormone agonist | 0.155 0.083 DBMET00347 | DBMET00347 | |
| 0.078 | 0.022 | 0.097 | Matrix metalloproteinase 1 inhibitor | 0.097 0.014 DBMET00347 | DBMET00347 | |
| 0.078 | 0.024 | 0.09 | Beta 3 adrenoreceptor antagonist | 0.09 0.018 DBMET00347 | DBMET00347 | |
| 0.115 | 0.062 | 0.115 | Alpha 2b adrenoreceptor antagonist | |||
| 0.091 | 0.041 | 0.091 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.093 | 0.043 | 0.1 | Myeloperoxidase inhibitor | 0.1 0.035 DBMET00347 | DBMET00347 | |
| 0.056 | 0.008 | 0.058 | ADAM10 endopeptidase inhibitor | 0.038 0.017 DBMET01581 0.058 0.007 DBMET00347 | DBMET00347 | |
| 0.066 | 0.019 | 0.066 | 5 Hydroxytryptamine 4 antagonist | 0.057 0.027 DBMET00347 | ||
| 0.067 | 0.021 | 0.067 | Neurokinin antagonist | |||
| 0.109 | 0.066 | 0.109 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.055 | 0.014 | 0.055 | Glycine transporter 1 inhibitor | 0.04 0.021 DBMET00347 | ||
| 0.075 | 0.034 | 0.075 | 5 Hydroxytryptamine 7 antagonist | |||
| 0.072 | 0.033 | 0.072 | 5 Hydroxytryptamine 3 agonist | |||
| 0.055 | 0.016 | 0.055 | GHS receptor agonist | 0.05 0.02 DBMET00347 | ||
| 0.08 | 0.042 | 0.084 | Thrombin inhibitor | 0.081 0.04 DBMET01581 0.084 0.038 DBMET00347 | DBMET00347 | |
| 0.072 | 0.035 | 0.072 | Acetylcholine M2 receptor antagonist | |||
| 0.064 | 0.03 | 0.064 | Protein kinase C theta inhibitor | 0.063 0.033 DBMET00347 | ||
| 0.06 | 0.026 | 0.06 | 5 Hydroxytryptamine 2 agonist | 0.054 0.033 DBMET00347 | ||
| 0.043 | 0.012 | 0.047 | CXC chemokine 3 receptor antagonist | 0.047 0.01 DBMET00347 | DBMET00347 | |
| 0.038 | 0.008 | 0.038 | 5 Hydroxytryptamine 1F agonist | |||
| 0.065 | 0.035 | 0.065 | Prolactin release inhibitor | |||
| 0.183 | 0.154 | 0.183 | Neuropeptide Y2 antagonist | |||
| 0.039 | 0.01 | 0.039 | Urotensin II agonist | 0.026 0.02 DBMET01581 | ||
| 0.079 | 0.051 | 0.079 | Viral attachment inhibitor | |||
| 0.067 | 0.04 | 0.074 | 5 Hydroxytryptamine 2A agonist | 0.074 0.033 DBMET00347 | DBMET00347 | |
| 0.044 | 0.018 | 0.052 | Bombesin 1 receptor antagonist | 0.033 0.031 DBMET01581 0.052 0.012 DBMET00347 | DBMET00347 | |
| 0.059 | 0.033 | 0.059 | 5 Hydroxytryptamine 7 agonist | |||
| 0.061 | 0.039 | 0.089 | Collagenase 3 inhibitor | 0.089 0.02 DBMET00347 | DBMET00347 | |
| 0.081 | 0.059 | 0.081 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.052 | 0.031 | 0.073 | Metalloproteinase-3 inhibitor | 0.073 0.018 DBMET00347 | DBMET00347 | |
| 0.03 | 0.01 | 0.034 | Aggrecanase 2 inhibitor | 0.034 0.009 DBMET00347 | DBMET00347 | |
| 0.106 | 0.085 | 0.106 | Calcium channel N-type blocker | |||
| 0.043 | 0.022 | 0.048 | Histone deacetylase 9 inhibitor | 0.048 0.017 DBMET00347 | DBMET00347 | |
| 0.043 | 0.025 | 0.043 | Neurokinin 1 antagonist | |||
| 0.059 | 0.042 | 0.086 | Bombesin 1 receptor agonist | 0.086 0.023 DBMET00347 | DBMET00347 | |
| 0.139 | 0.126 | 0.139 | Psychostimulant | 0.136 0.13 DBMET01581 | ||
| 0.037 | 0.025 | 0.037 | Somatostatin 4 agonist | |||
| 0.039 | 0.027 | 0.039 | Somatostatin 1 antagonist | 0.038 0.027 DBMET00347 | ||
| 0.053 | 0.042 | 0.053 | Epithelial sodium channel blocker | |||
| 0.046 | 0.036 | 0.049 | Bombesin antagonist | 0.049 0.03 DBMET00347 | DBMET00347 | |
| 0.121 | 0.112 | 0.121 | MAP3K9 inhibitor | |||
| 0.054 | 0.044 | 0.116 | Plasminogen activator inhibitor | 0.116 0.012 DBMET01581 0.05 0.048 DBMET00347 | DBMET01581 | |
| 0.121 | 0.111 | 0.133 | Anticoagulant | 0.133 0.097 DBMET01581 0.125 0.105 DBMET00347 | DBMET01581 | |
| 0.036 | 0.027 | 0.036 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.02 | 0.012 | 0.024 | Follicle-stimulating hormone antagonist | 0.024 0.006 DBMET00347 | DBMET00347 | |
| 0.037 | 0.029 | 0.045 | Factor X inhibitor | 0.045 0.024 DBMET01581 0.035 0.03 DBMET00347 | DBMET01581 | |
| 0.078 | 0.07 | 0.078 | Factor XII inhibitor | 0.077 0.074 DBMET00347 | ||
| 0.035 | 0.027 | 0.044 | Histone deacetylase 7 inhibitor | 0.044 0.021 DBMET00347 | DBMET00347 | |
| 0.061 | 0.053 | 0.086 | Kallikrein 7 inhibitor | 0.086 0.009 DBMET01581 0.063 0.046 DBMET00347 | DBMET01581 | |
| 0.029 | 0.024 | 0.029 | Somatostatin agonist | |||
| 0.048 | 0.044 | 0.048 | Cannabinoid CB2 receptor agonist | 0.047 0.045 DBMET00347 | ||
| 0.063 | 0.06 | 0.066 | I kappa B kinase 1 inhibitor | 0.066 0.054 DBMET00347 | DBMET00347 | |
| 0.029 | 0.027 | 0.034 | Growth hormone releasing factor agonist | 0.034 0.023 DBMET00347 | DBMET00347 | |
| 0.092 | 0.09 | 0.106 | Nav1.4 sodium channel blocker | 0.106 0.067 DBMET01581 | DBMET01581 | |
| 0.043 | 0.041 | 0.043 | Cholesterol esterase inhibitor | |||
| 0.02 | 0.018 | 0.02 | Urotensin II antagonist | |||
| 0.026 | 0.025 | 0.026 | CDK4/cyclin D3 inhibitor | |||
| 0.035 | 0.04 | 0.045 | Macrophage elastase inhibitor | 0.045 0.029 DBMET00347 | DBMET00347 | |
| 0.033 | 0.042 | 0.037 | Growth hormone release inhibitor | 0.037 0.036 DBMET00347 | DBMET00347 | |
| 0.055 | 0.065 | 0.083 | Trypsin inhibitor | 0.083 0.025 DBMET01581 | DBMET01581 | |
| 0.049 | 0.061 | 0.057 | Cannabinoid receptor agonist | 0.057 0.051 DBMET00347 | DBMET00347 | |
| 0.016 | 0.028 | 0.023 | Follicle-stimulating hormone agonist | 0.023 0.014 DBMET00347 | DBMET00347 | |
| 0.049 | 0.061 | 0.106 | Adrenaline uptake inhibitor | 0.106 0.017 DBMET00347 | DBMET00347 | |
| 0.034 | 0.046 | 0.059 | Histamine H2 receptor agonist | 0.059 0.015 DBMET00347 | DBMET00347 | |
| 0.026 | 0.039 | 0.046 | Melatonin 1 agonist | 0.046 0.011 DBMET00347 | DBMET00347 | |
| 0.036 | 0.051 | 0.043 | Melanocortin antagonist | 0.043 0.039 DBMET00347 | DBMET00347 | |
| 0.027 | 0.043 | 0.031 | Melatonin receptor 1A agonist | 0.031 0.028 DBMET00347 | DBMET00347 | |
| 0.03 | 0.049 | 0.037 | Melanocortin 4 antagonist | 0.037 0.035 DBMET00347 | DBMET00347 | |
| 0.021 | 0.041 | 0.036 | Trypsin I inhibitor | 0.036 0.021 DBMET01581 | DBMET01581 | |
| 0.035 | 0.058 | 0.041 | Histamine H1 receptor agonist | 0.041 0.037 DBMET00347 | DBMET00347 | |
| 0.022 | 0.048 | 0.043 | Melatonin agonist | 0.043 0.013 DBMET00347 | DBMET00347 | |
| 0.031 | 0.058 | 0.083 | Plasmin inhibitor | 0.083 0.021 DBMET01581 | DBMET01581 | |
| 0.168 | 0.202 | 0.276 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.276 0.083 DBMET01581 | DBMET01581 | |
| 0.059 | 0.094 | 0.102 | Adrenaline agonist | 0.102 0.035 DBMET00347 | DBMET00347 | |
| 0.019 | 0.06 | 0.04 | 1,3-Beta-glucan synthase inhibitor | 0.04 0.004 DBMET01581 | DBMET01581 | |
| 0.011 | 0.068 | 0.029 | Melatonin antagonist | 0.029 0.018 DBMET00347 | DBMET00347 | |
| 0.033 | 0.092 | 0.044 | Baculoviral IAP repeat-containing protein inhibitor | 0.044 0.039 DBMET00347 | DBMET00347 | |
| 0.031 | 0.097 | 0.055 | Alpha 1 adrenoreceptor agonist | 0.055 0.043 DBMET00347 | DBMET00347 | |
| 0.043 | 0.114 | 0.056 | Immunoglobulin Fc receptor antagonist | 0.056 0.034 DBMET00347 | DBMET00347 | |
| 0.101 | 0.176 | 0.134 | Adenylate cyclase stimulant | 0.134 0.093 DBMET00347 | DBMET00347 | |
| 0.014 | 0.111 | 0.037 | Melatonin 2 agonist | 0.037 0.018 DBMET00347 | DBMET00347 | |
| 0.136 | 0.246 | 0.188 | Gastrin inhibitor | 0.188 0.167 DBMET00347 | DBMET00347 | |
| 0.025 | 0.171 | 0.052 | Carbonic anhydrase stimulant | 0.052 0.051 DBMET00347 | DBMET00347 | |
| 0.039 | 0.226 | 0.081 | Protein kinase C mu inhibitor | 0.081 0.079 DBMET01581 | DBMET01581 | |
| 0.015 | 0.243 | 0.068 | Elastase inhibitor | 0.068 0.023 DBMET01581 | DBMET01581 | |
| 0.045 | 0.341 | 0.115 | Toll-Like receptor 3 antagonist | 0.115 0.034 DBMET00347 | DBMET00347 | |
| 0.021 | 0.499 | 0.133 | Chymotrypsin inhibitor | 0.133 0.021 DBMET01581 | DBMET01581 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |